GPNMB triggers the self-renewal of spheroids to increase cell survival and the tumor-forming ability of macrophages interacting with tumor cells, and GPNMB activates the expression of the IL-33cytokine and its receptor, IL-1R1L, through CD47 and is sufficient to induce tumor spheroid formation [34]. This evidence concerns the gene CD47 and neoplasm.